119 related articles for article (PubMed ID: 19063607)
1. Residues responsible for the asymmetric function of the nucleotide binding domains of multidrug resistance protein 1.
Qin L; Zheng J; Grant CE; Jia Z; Cole SP; Deeley RG
Biochemistry; 2008 Dec; 47(52):13952-65. PubMed ID: 19063607
[TBL] [Abstract][Full Text] [Related]
2. Role of carboxylate residues adjacent to the conserved core Walker B motifs in the catalytic cycle of multidrug resistance protein 1 (ABCC1).
Payen LF; Gao M; Westlake CJ; Cole SP; Deeley RG
J Biol Chem; 2003 Oct; 278(40):38537-47. PubMed ID: 12882957
[TBL] [Abstract][Full Text] [Related]
3. A functional role of intracellular loops of human multidrug resistance protein 1.
Ren XQ; Furukawa T; Yamamoto M; Aoki S; Kobayashi M; Nakagawa M; Akiyama S
J Biochem; 2006 Sep; 140(3):313-8. PubMed ID: 16861249
[TBL] [Abstract][Full Text] [Related]
4. The Walker B motif of the second nucleotide-binding domain (NBD2) of CFTR plays a key role in ATPase activity by the NBD1-NBD2 heterodimer.
Stratford FL; Ramjeesingh M; Cheung JC; Huan LJ; Bear CE
Biochem J; 2007 Jan; 401(2):581-6. PubMed ID: 16989640
[TBL] [Abstract][Full Text] [Related]
5. ATP binding to the first nucleotide binding domain of multidrug resistance-associated protein plays a regulatory role at low nucleotide concentration, whereas ATP hydrolysis at the second plays a dominant role in ATP-dependent leukotriene C4 transport.
Yang R; Cui L; Hou YX; Riordan JR; Chang XB
J Biol Chem; 2003 Aug; 278(33):30764-71. PubMed ID: 12783859
[TBL] [Abstract][Full Text] [Related]
6. ATP binding to the first nucleotide-binding domain of multidrug resistance protein MRP1 increases binding and hydrolysis of ATP and trapping of ADP at the second domain.
Hou YX; Cui L; Riordan JR; Chang XB
J Biol Chem; 2002 Feb; 277(7):5110-9. PubMed ID: 11741902
[TBL] [Abstract][Full Text] [Related]
7. Nucleotide binding, ATP hydrolysis, and mutation of the catalytic carboxylates of human P-glycoprotein cause distinct conformational changes in the transmembrane segments.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2007 Aug; 46(32):9328-36. PubMed ID: 17636884
[TBL] [Abstract][Full Text] [Related]
8. Function of the ABC signature sequences in the human multidrug resistance protein 1.
Ren XQ; Furukawa T; Haraguchi M; Sumizawa T; Aoki S; Kobayashi M; Akiyama S
Mol Pharmacol; 2004 Jun; 65(6):1536-42. PubMed ID: 15155846
[TBL] [Abstract][Full Text] [Related]
9. Functional studies on the MRP1 multidrug transporter: characterization of ABC-signature mutant variants.
Szentpétery Z; Sarkadi B; Bakos E; Váradi A
Anticancer Res; 2004; 24(2A):449-55. PubMed ID: 15152943
[TBL] [Abstract][Full Text] [Related]
10. Nucleotide-binding sites of the heterodimeric LmrCD ABC-multidrug transporter of Lactococcus lactis are asymmetric.
Lubelski J; van Merkerk R; Konings WN; Driessen AJ
Biochemistry; 2006 Jan; 45(2):648-56. PubMed ID: 16401093
[TBL] [Abstract][Full Text] [Related]
11. Stoichiometry and affinity of nucleotide binding to P-glycoprotein during the catalytic cycle.
Qu Q; Russell PL; Sharom FJ
Biochemistry; 2003 Feb; 42(4):1170-7. PubMed ID: 12549939
[TBL] [Abstract][Full Text] [Related]
12. The exceptionally tight affinity of DnaA for ATP/ADP requires a unique aspartic acid residue in the AAA+ sensor 1 motif.
Kawakami H; Ozaki S; Suzuki S; Nakamura K; Senriuchi T; Su'etsugu M; Fujimitsu K; Katayama T
Mol Microbiol; 2006 Dec; 62(5):1310-24. PubMed ID: 17042785
[TBL] [Abstract][Full Text] [Related]
13. ATP hydrolysis promotes interactions between the extracellular ends of transmembrane segments 1 and 11 of human multidrug resistance P-glycoprotein.
Loo TW; Bartlett MC; Clarke DM
Biochemistry; 2005 Aug; 44(30):10250-8. PubMed ID: 16042402
[TBL] [Abstract][Full Text] [Related]
14. ABC multidrug transporter Cdr1p of Candida albicans has divergent nucleotide-binding domains which display functional asymmetry.
Jha S; Dabas N; Karnani N; Saini P; Prasad R
FEMS Yeast Res; 2004 Oct; 5(1):63-72. PubMed ID: 15381123
[TBL] [Abstract][Full Text] [Related]
15. Modulator-induced interference in functional cross talk between the substrate and the ATP sites of human P-glycoprotein.
Maki N; Moitra K; Silver C; Ghosh P; Chattopadhyay A; Dey S
Biochemistry; 2006 Feb; 45(8):2739-51. PubMed ID: 16489767
[TBL] [Abstract][Full Text] [Related]
16. Involvement of the "occluded nucleotide conformation" of P-glycoprotein in the catalytic pathway.
Tombline G; Muharemagić A; White LB; Senior AE
Biochemistry; 2005 Sep; 44(38):12879-86. PubMed ID: 16171403
[TBL] [Abstract][Full Text] [Related]
17. Functional interactions between nucleotide binding domains and leukotriene C4 binding sites of multidrug resistance protein 1 (ABCC1).
Payen L; Gao M; Westlake C; Theis A; Cole SP; Deeley RG
Mol Pharmacol; 2005 Jun; 67(6):1944-53. PubMed ID: 15755910
[TBL] [Abstract][Full Text] [Related]
18. Functional importance of polar and charged amino acid residues in transmembrane helix 14 of multidrug resistance protein 1 (MRP1/ABCC1): identification of an aspartate residue critical for conversion from a high to low affinity substrate binding state.
Zhang DW; Gu HM; Situ D; Haimeur A; Cole SP; Deeley RG
J Biol Chem; 2003 Nov; 278(46):46052-63. PubMed ID: 12954620
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the Walker B motif in the first nucleotide binding domain of multidrug resistance protein MRP1 prevent conformational maturation.
Cui L; Hou YX; Riordan JR; Chang XB
Arch Biochem Biophys; 2001 Aug; 392(1):153-61. PubMed ID: 11469806
[TBL] [Abstract][Full Text] [Related]
20. Mutation of the aromatic amino acid interacting with adenine moiety of ATP to a polar residue alters the properties of multidrug resistance protein 1.
Zhao Q; Chang XB
J Biol Chem; 2004 Nov; 279(47):48505-12. PubMed ID: 15355964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
